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Abstract
The exploration of poorly studied areas of Earth can highly increase the possibility to discover novel bioactive compounds. In this
study, the cultivable fraction of fungi and bacteria from Barents Sea sediments has been studied to mine new bioactive molecules
with antibacterial activity against a panel of human pathogens.We isolated diverse strains of psychrophilic and halophilic bacteria
and fungi from a collection of nine samples from sea sediment. Following a full bioassay-guided approach, we isolated a new
promising polyextremophilic marine fungus strain 8Na, identified as Aspergillus protuberusMUT 3638, possessing the potential
to produce antimicrobial agents. This fungus, isolated from cold seawater, was able to grow in a wide range of salinity, pH and
temperatures. The growth conditions were optimised and scaled to fermentation, and its produced extract was subjected to
chemical analysis. The active component was identified as bisvertinolone, a member of sorbicillonoid family that was found
to display significant activity against Staphylococcus aureus with a minimum inhibitory concentration (MIC) of 30 μg/mL.
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Introduction
Antimicrobial resistance has spread dramatically in the last
30 years, leading to an increase in the number of deaths due
to infectious diseases. The excessive and often inappropriate
use of antimicrobial drugs has affected the development of a
new group of microorganisms, the multidrug-resistant (MDR)
bacteria, which show resistance towards the most common
antibiotics (Muller et al. 2017). Currently, there is a pressing
need to discover novel and effective antimicrobial drugs to
counteract this dramatic emergence of MDR infections.
Nature has always been the main source of new molecular
scaffolds; a prime example was the discovery of penicillin.
Henceforth, bioprospecting of marine macro- and microor-
ganisms for new natural drug candidates still represents the
best opportunity for the discovery of new bioactive com-
pounds. In particular, extreme environments constitute an un-
explored reservoir of biodiversity (Poli et al. 2017). The use of
different strategies of adaptation by organisms and microor-
ganisms allowed the colonisation of extreme habitats, which
are characterised by low nutrient concentration, extremes of
pH, low temperature, high pressure and salinity. Some of the
most extreme marine habitats known like Mediterranean deep
hypersaline anoxic basins (DHABs; water depth ∼ 3500 m)
are nearly saturated with salt, from these sediments were re-
trieved different halotolerant/halophilic fungal groups that
might have adapted to different local environments
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(Bernhard et al. 2014). Currently, particular attention has been
focused on marine fungi (Zhao et al. 2016; Saleem et al.
2007), since they are considered an interesting untapped re-
source of biodiversity and biotechnological potential for pro-
duction of secondary metabolites (Ebada and Proksch 2015).
The ability to grow in different ranges of salt concen-
tration is probably one of the most remarkable features
of some species of marine fungi that could confer the
potential to synthesise new bioactive metabolites
(Gostincar et al. 2010). Particularly, under hypersaline
conditions, the cell keeps its stability and integrity accu-
mulating compatible solutes in its interior to overcome
osmotic stress and to prevent lysis (Delgado-Jarana et al.
2006). This condition induces changes in the membrane
composition that effectively increases the sterol to phos-
pholipid ratio, and the fatty acid unsaturation in turn
increases the membrane fluidity (Turk et al. 2004).
Among all marine fungi, Penicillium and Aspergillus
are a very powerful source of new bioactive compounds
(Blunt et al. 2015). The genus Aspergillus is widespread
all over the marine ecosystem. Aspergillus sp. fungi are
heterotroph and polyextremophiles. This significant nu-
tritional and physiological versatility is complemented by
the metabolic capacity to produce numerous secondary
metabolites, which is believed to be important in ecolog-
ical signalling (Baker and Bennett 2007). Genomic stud-
ies are revealing putative biosynthetic genes of
Aspergillus strains; however, the biocomposites described
in the literature are still limited. The prediction of genes
exceeds the number of new molecules obtained so far,
leaving a large number of compounds yet to be discov-
ered (Rateb and Ebel 2011).
Despite the fact that natural products from some fungal
genera have been often and intensively studied, in particular,
Aspergillus and Penicillium, there is still a great potential of
secondary metabolites produced by these fungi, which have
not as yet been fully and adequately explored.
Barents Sea is part of Arctic Continental Shelf, and it is also
the deepest of the Arctic shelf seas. The most distinctive
oceanographic feature of the Barents Sea is the influx of the
salty Atlantic waters from the southwest that meets and mixes
with Arctic water masses along the Polar Front (Loeng 1991).
This condition makes the Barents Sea warmer in comparison
with other areas of the same latitude, but the oceanographic
conditions are highly variable. Barents Sea is a poorly ex-
plored environment, and therefore it is an appealing prospect
within the biodiscovery pipeline.
Herein, we report the isolation of 14 fungi from marine
sediments collected in the Barents Sea and their taxonomic
characterisation. Furthermore, we also report the identification
of a sorbicillonoid-producing strain of Aspergillus protuberus
MUT 3638, a species recently described belonging to the
Aspergillus section Versicolores (Jurjevic et al. 2012), and
the isolation of bisvertinolone as an active antimicrobial
component.
Materials and Methods
Sediment Collection
The strains used in this work were isolated from sub-sea sed-
iments collected from the Barents Sea (Fig. 1), during the
Barkut expedition in June 2015, in collaboration with Prof.
Bjarne Landfald of the University of Tromsø. Sediments were
collected from nine different sampling sites and depths
(Table 1) using a multicorer drill device. Several layers were
cut and then aseptically placed into 50-mL conical tubes and
kept at 4 °C during the shipments and stored at − 80 °C after
their arrival to the laboratory.
Culture Media
Specific culture media were designed for the isolation of dif-
ferent groups of psychrophilic and halotolerant/halophilic mi-
croorganisms present in extreme marine environments. Each
medium was prepared with natural seawater and artificial sea-
water in a range of six salinities [3, 5, 10, 15, 20 and 25% (w/v)
of total salts] and three different pH conditions. Natural sea-
water was used to prepare media with a basal salt concentra-
tion in order to mimic the marine environment (3–3.5% of
total salinity) while a stock solution of artificial seawater
SW30 (Subov’s salt solution 30% (w/v)) was used to prepare
other media with higher salt concentrations.
All media except LB were adjusted to three different pH
values (4.0, 7.0 and 9.0) and sterilised by autoclaving at
121 °C for 15 min. The names and formula of each medium
are given in grams per litre, and for solid media, 20 g/L of agar
was added.
Artificial seawater (SW30): 234.0 g NaCl, 39.0 g MgCl2·
6H2O, 61.0 g MgSO4·7H2O, 1.0 g
*CaCl2; 6.0 g KCl, 0.2 g
NaHCO3, 0.7 g NaBr. This medium was prepared with dis-
tilled water up to 1000mL. *CaCl2 was dissolved separately in
20 mL of distilled water to prevent the formation of insoluble
complexes of CaCO3.
The following media were prepared dissolving the com-
pounds in natural seawater. For media with higher salinities,
the artificial seawater SW30 diluted in distilled water was
used to reach the salt concentration required.
Seawater minimal (SWM): 1.0 g casamino acids, 1.0 g
yeast extract, 1.0 g peptone, 1.0 g glucose.
Casein yeast chitin (CYC): 5.0 g casein, 0.5 g yeast ex-
tract, 5.0 g chitin, 0.5 g K2HPO4, 5.0 g malt extract, 0.1 g
sodium pyruvate salt, 500 μL glycerol.
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Tryptone yeast starch (TYS): 10.0 g tryptone, 5.0 g yeast
extract, 0.5 g starch, 10.0 g NaCl, 0.5 g malt extract, 0.1 g
sucrose, 500 μL glycerol.
Malt yeast extract (MY): 10.0 g malt extract, 4.0 g yeast
extract, 4.0 g glucose.
Luria Bertani (LB): 10.0 g tryptone, 5.0 g yeast extract,
10.0 g NaCl, pH 7 (20.0 g agar for solid media). This
mediumwas prepared with distilled water up to 1000mL.
Isolation of Microorganisms
Standard protocols for air quality controls were performed to
discriminate contaminations. The bacterial and mould tests
consisted of leaving opened for 1 h a Petri dish with LB agar
for bacteria and Sabouraud agar for moulds, then closed and
room temperature incubated for 7 to 14 days. Besides bacteria
and mould testing, controls were always included with all
media used in this work and incubated with the rest of samples
at the temperature and time programmed.
Further of standard disinfection, all microbiological proce-
dures: culture, isolation and screenings were rigorously per-
formed under a biosafety cabinet class II with a laminar flow
to reduce contamination by airborne spores.
For the isolation of microorganisms, two different growth
media were used: SWM for bacteria and CYC for
actinobacteria and fungi. Both media with increasing salt con-
centrations ranging from 3% to 25% (w/v) for the isolation of
halotolerant and moderate to halophilic microorganisms.
In order to isolate microorganisms, 1.0 g of sediment was
mixed with 9 mL of filtered and sterilised natural seawater
(NSW) in a 15-mL conical tube and gently mixed. The super-
natant was then serially diluted tenfold until 10−6 dilution (i.e.
10−1, 10−2, 10−3, 10−4), and 100 μL of the serial dilution was
spread plated on sterile SWM and CYC Petri dishes.
The inoculated plates and controls were incubated for 5 to
20 days at two different temperatures, 4 and 15 °C. Then,
several colonies were picked using as criteria the morphology,
size and pigments and were then incubated for 5–6 days at
20 °C with agitation in liquid medium SWM and CYC, re-
spectively. All the microorganisms isolated were suspended in
glycerol (10% (v/v) for fungal strains, and 20% for the bacte-
rial strains, of the final volume) and stored at − 80 °C in cryo-
genic vials.
Identification of Fungal Strains
The isolated fungi were identified with a polyphasic approach,
which couples morpho-physiological features with molecular
studies. After determination of the genera according to the
macroscopic and microscopic features (Domsch et al. 1980),
a) b) 
Table 1 Coordinates and depth of several sampling sites from Barents
Sea
Sampling location Latitude and longitude Depth (m)
Bjørnøyenna 72° 20′ 07″ N; 18° 09′ 50″ E 364
Salina 72° 00′ 97″ N; 20° 03′ 46″ E 345
Well 7119 71° 12′ 87″ N; 20° 03′ 46″ E 204
Well 7120-1 71° 07′ 65″ N; 20° 48′ 97″ E 163
Well 7120-2 71° 12′ 87″ N; 19° 56′ 59″ E 165
Bønna 70° 50′ 05″ N; 16° 33′ 20″ E 1365
Goliat 71° 17′ 09″ N; 22° 19′ 38″ E 380
Repparfjord 70° 27′ 59″ N; 24° 17′ 17″ E 47
HammerFest 70° 39′ 69″ N; 23° 40′ 12″ E 46
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Fig. 1 Geographic localisation of the Barents Sea. a The area where sampling was performed is circled. b The city and the fiord of Hammerfest and final
leg of the mission are highlighted.
the fungal strains were transferred to the media recommended
by the authors of a selected genus monographs for species
identification. For molecular identification, genomic DNA of
all strains was extracted from approximately 100 mg of my-
celium, scraped fromMY Petri dishes, using a NucleoSpin kit
(Macherey Nagel GmbH, Duren, DE, USA), according to the
manufacturer instructions. The quality and quantity of DNA
samples were measured with the ND-1000 Spectrophotometer
NanoDropH (Thermo Scientific, Wilmington, Germany).
DNA extracts were stored at − 20 °C. The ITS sequences were
amplified using the primer pair ITS1/ITS4 (White et al. 1990).
For those strains morphologically identified as Aspergillus
spp. and Penicillium spp., amplification of the β-tubulin gene
was performed using primers Bt2a/Bt2b (Glass and
Donaldson 1995; Geiser et al. 1998). Reaction mixtures
consisted of 30 ng genomic DNA, 1 μM each primer, 1 U
Taq DNA Polymerase (Qiagen, Chatsworth, CA, USA), 1×
reaction buffer and 200 μM of dNTPs. DNA amplifications
were performed using a T-Gradient thermal cycler (Biometra,
Göttingen, Germany) with the following profile: 95 °C for
5 min; 35 cycles: 95 °C for 40 s, 55 °C (58 °C for
Bt2a/Bt2b) for 45 s, 72 °C for 50 s; 72 °C for 8 min. PCR
products were purified and sequenced at Macrogen Europe
Laboratory (Amsterdam, The Netherlands).
All strains were taxonomically identified at the species lev-
el. The partial sequences obtained were verified and analysed
by querying with the Blastn algorithm (default setting; mis-
match 1/−2; gap cost linear) hosted at NCBI, the specific
sequences against the GenBank (http://www.ncbi.nlm.nih.
gov). Pairwise alignments were also performed using the
sequence database of the Westerdijk Fungal Biodiversity
Institute (http://www.westerdijkinstitute.nl/).
Finally, dereplication of the isolates belonging to the same
species was performed applying the microsatellite screening
by using the core sequence of the microsatellite M-13 as a
primer (Abd-Elsalam et al. 2010). Amplicons were separated
on 1.5% (w/v) agarose gels stained with 5 μL 100 mL−1
ethidium bromide and electrophoresed alongside a GelPilot
1 kb plus DNA Ladder; images were acquired with a Gel
Doc 1000 System (Bio-Rad, Hercules, CA, USA), and finger-
prints were analysed using Bionumerics 7.1 software.
Pathogenic Strains
The following human pathogens were used in this work:
Pseudomonas aeruginosa PA01 (Alonso et al. 1999),
Staphylococcus aureus 6538P (Lima et al. 2014), Klebsiella
pneumoniae DF12SA (Shahi et al. 2013), Acinetobacter
baumannii Ab13 (Poirel et al. 2008), Burkholderia
cenocepacia LMG 16656 and Burkholderia metallica LMG
24068 (Soriano et al. 2009). The strains were routinely grown
at 37 °C in LB medium.
Primary Screening for Antagonistic Activity
Preliminary screening for antimicrobial activity was per-
formed by the cross-streaking method against a panel of hu-
man pathogens (BPathogenic Strains^). This method allows
the observation of antagonistic interactions among a tester
strain and several target strains. To overcome the limitation
of the assay that the pathogen and the tested strain are not able
to grow on the same medium, a dual media Petri dish was
developed. From one side of the plate, the culture medium
was poured to allow the growth of marine bacterial or fungal
isolates (SWM or TYS), and the other half of the plate was
filled with LBmedium, suitable for the growing of pathogenic
bacteria. The tester strains were selected on the basis of dif-
ferent morphologies, pigments and shapes and were streaked
onto one side of the plate with their appropriate medium and
then incubated at 20 °C for 10 days. Thereafter, the pathogenic
strains were streaked perpendicularly to the initial streak and
incubated at 37 °C for 24 h. A control plate using the patho-
gens was also maintained without inoculating the marine fun-
gal strains, to assess the normal growth of pathogenic bacteria.
Preparation of Crude Extracts
A pre-inoculumwas prepared from the active fungal strains. A
small piece of mycelium was inoculated in 3 mL of liquid
medium TYS and incubated for 5 days at 20 °C. This pre-
inoculum was used to inoculate 250 mL of the same medium
in 500-mL flasks and incubated at different temperatures and
days in a static condition. Thereafter, exhausted culture broths
were centrifuged at 7000 rpm for 30 min at 4 °C. For the
extracellular extraction, the supernatant was mixed and vigor-
ously shaken five times with three volumes of ethyl acetate
using a separator funnel. This mixing facilitated the transfer of
a dissolved compound from one solvent layer to another.
Finally, the solvent was dried using a Laborota 4000 Rotary
Evaporator (Heidolph, Schwabach, Germany). The extract
was weighed and dissolved in DMSO (100%) at a final con-
centration of 100 mg/mL.
Liquid Inhibition Assay
The produced crude extracts were checked for their ability to
inhibit the growth of a selected panel of human pathogens,
using a liquid inhibition assay in 96-well plates. The different
extracts were placed into each well at an initial concentration
of 2 mg/mL and were serially diluted twofold using the ap-
propriate medium. Wells that contained no compounds repre-
sented the negative control. DMSO (2% (v/v)) was also used
as control to determine the effect of the solvent on bacterial
growth. A single colony of each pathogenic strain was used to
inoculate 3 mL of LB broth in sterile bacteriological tube.
After 5–8 h of incubation, the growth was measured by
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monitoring the absorbance at 600 nm. The cells were then
diluted using OD/CFU correlation growth curves, and about
40,000 CFU were dispensed into each well containing the
dilutions of the compound. Wells not containing any com-
pounds were used as negative control. Plates were incubated
at 37 °C overnight, and growth was measured using a
VICTOR X Multilabel Plate Reader (PerkinElmer, Waltham,
MA) by monitoring the absorbance at 600 nm.
Purification of Active Compounds from the Newly
Isolated A. protuberus MUT 3638
The crude extract obtained as described (BCompound
Identification^) was subjected to fractionation using
Chromabond SPE C18 column cartridges (Macherey-Nagel,
Duren, Germany) and selectively eluted with different per-
centages of a methanol-water system. The fractions obtained
were subsequently screened again to identify the activity. The
active fraction was further purified by reverse-phase high-per-
formance liquid chromatography (HPLC) using a C18 col-
umn. HPLC separations were carried out using a 5-μm
Nucleodur reversed-phase HTec (C18, 250/10 mm, L × i.d.)
column connected to an UltiMate 3000 series pump with an
UltiMate photodiode array detector and in-line degasser
(Dionex, Sunnyvale, CA). Detection was carried out at 220,
254, 280 and 320 nm. Elution was carried out at 2.00 mL/min
with a 46-min linear gradient of acetonitrile:water:trifluoroacetic
acid. The peaks were manually collected, dried and tested for
bioactivity.
Liquid Chromatography High-Resolution Mass
Spectrometry
The crude extract from the fungus MUT 3638 was subjected
to preliminary chemical profiling.
The analyses were carried out on a Dionex Ultimate 3000
quaternary system coupled to a hybrid linear ion trap LTQ
Orbitrap XLTM Fourier Transform MS (FTMS) equipped
with an ESI ION MAXTM source (Thermo-Fisher, San
José, CA, USA). Chromatographic separation was accom-
plished by using a Kinetex C18 column, 2.6 μm, 2.10 ×
100mm (Phenomenex, USA)maintained at room temperature
and eluted at 0.2 mL min−1 with water (eluent A) and aceto-
nitrile (eluent B), both containing 0.1% (v/v) formic acid. The
following gradient elution was used: 20% B at t = 0, 95% B at
t = 30min and hold for 5 min; re-equilibration time was 9 min.
Injection volume was 5 μL.
Nuclear Magnetic Resonance Method
Spectral data for bisvertinolone 1H NMR spectrum of
bisvertinolone was obtained on Varian Inova 500 NMR and
recorded in CDCl3 (δH = 7.26 and δC = 77.0 ppm) and DMSO
(δH = 3.50). High-resolution full MS experiments (positive
ions) were acquired in the m/z 100–1000 range at a resolving
power of 30,000. The following source settings were used:
spray voltage = 4.5 kV, capillary temperature = 400 °C, capil-
lary voltage = 29 V, sheath gas flow = 34 and auxiliary gas
flow = 0 (arbitrary units) and tube lens voltage = 115 V.
Thermo Scientific software Xcalibur has been used to obtain
molecular formula. The calibration procedure was carried out
using Thermo Scientific positive calibration solution com-
posed by caffeine, Met-Arg-Phe-Ala (MRFA) and Ultramark.
Bisvertonolone Light yellow amorphous powder; 1H NMR
(500 MHz, CDCl3) δ (ppm): 7.58 (1H, dd, J = 14.8, 9.7 Hz,
H-12), 7.42 (1H, d, J = 14.8 Hz, H-11), 7.32 (1H, dd, J= 14.6,
11.6 Hz, H-21), 6.40 (1H, d, J= 14.6 Hz, H-20), 6.37 (3H, ovl,
H-13, H-14 and H-22), 6.14 (1H, m, H-23), 3.75 (1H, s, H-9a),
1.93 (3H, d, J = 4.8 Hz, H3–15), 1.89 (3H, d, J = 6.5 Hz, H3–24),
1.49 (3H, s, H3-C7), 1.47 (3H, s, H3-C4), 1.45 (3H, s, H3-C5a),
1.38 (3H, s, H3-C9b) (see Fig. S4 supplemental material).
HRESIMS: calculated for C28H33O9 513.2119, found
513.2124 [M + H]+ (see Fig. S3 supplemental material).
HRESI MSMS (major fragmentation peaks) 495.2012
(C28H31O8), 477.1905 (C28H29O7), 265.1070 (C14H17O5),
249.1121 (C14H17O4), 207.0651 (C11H11O4), 95.0489 (C6H7O)
(see Fig. S5 supplemental material).
Results and Discussion
Isolation of Marine Microorganisms
From a total of 9 sea sediment samples, 85 microorganisms
were isolated; specifically, 75 of them were identified as bac-
teria and the remaining 14 were identified as fungi. No bacte-
ria or Achaea were isolated using media from 15 to 25% (w/v)
of total salts, while the total population of fungi was isolated
by diluting the sediments in growth media at varying salt
concentrations.
Identification of Fungal Strains
All the isolated fungi were identified using a polyphasic ap-
proach, according to their macroscopic and microscopic fea-
tures, as well as by molecular analysis. The 14 isolated strains
belong to the Ascomycota phylum: Aspergillus protuberus
(seven strains), Penicillium rubens (three strains),
Penicillium chrysogenum (two strains), Aspergillus sydowii
andMicroascus trigonosporus (one strain). Sequences related
to the fungi isolated in this study were deposited at the NCBI
database. GenBank accession numbers are reported in Table 2.
The dereplication analysis showed that only two strains were
isogenic within the same species (see Fig. S1, Supplementary
materials), demonstrating that the isolation procedure using
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different media and different salinity is a powerful tool to
retrieve more strains. All identified isolates were stored and
preserved in the fungal collection bank, Mycotheca
Universitatis Taurinensis (MUT) from the University of
Turin. The 14 strains deposited were assigned with the culture
collection code MUT. The main features of identification are
reported in Table 2.
Antimicrobial Screening
A preliminary screening by cross-streaking (CT) revealed that
only the fungus MUT 3638, identified as Aspergillus
protuberus, was able to inhibit completely the growth of four
pathogens from the panel tested: Staphylococcus aureus,
Klebsiella pneumoniae, Acinectocater baumanii and
Burkholderia metallica with the exception of Pseudomonas
aeruginosa that was not inhibited by the fungal strains. The
qualitative interpretation is shown in Fig. S2.
As a fact, the anticancer, antimicrobial and antiviral poten-
tials of marine fungi especially of Aspergillus and Penicillium
are well known (Xu et al. 2015). Among these candidates,
fungal strainMUT 3638was selected, since it showed the best
inhibitory activity compared to the other tested strains. The
antimicrobial activity of all fungal strains is summarised in
Table 3. Therefore, MUT 3638 was selected for up-scaled
fermentation, growth optimisation and purification of the mol-
ecule involved in the antimicrobial activity.
Growth Optimisation for Antimicrobial Production
MUT 3638 was initially isolated at 15% (w/v) of salinity in
media CYC. In order to optimise the growth conditions for the
Table 2 Identification of the
isolated fungi preserved in MUT
culture collection
Isolated
strain
Sampling
site
Final identification (taxa) Isolation
media
MUT
code
GenBank acc.
#
1Na Goliat Penicillium rubens CYC 15% 3588 MF574999
1Nb Goliat Penicillium chrysogenum CYC 20% 3589 MF575000
2Aa Repparfjord Penicillium chrysogenum CYC 20% 3596 MF575001
3Na HammerFest Penicillium rubens CYC 20% 3597 MF575002
4Na Salina Aspergillus sydowii CYC 20% 3610 MF575003
4Nb Salina Microascus
trigonosporus
CYC 5% 3612 MF509599
5Ea Bjørnøyenna Aspergillus protuberus CYC 20% 3613 MF575004
5Na Bjørnøyenna Aspergillus protuberus CYC 5% 3614 MF575005
5Nb* Bjørnøyenna Aspergillus protuberus CYC 15% 3615 MF575006
5Nc*
6Na Bønna Penicillium rubens CYC 3% 3616 MF575007
7Na Bønna Aspergillus protuberus CYC 10% 3617 MF575008
7Nb Bønna Aspergillus protuberus CYC 10% 3618 MF575009
7Nc Bønna Aspergillus protuberus CYC 10% 3632 MF575010
8Na Bønna Aspergillus protuberus CYC 15% 3638 MF150910
*Strains 5Nb and 5Nc were considered isogenic because of genetic dereplication; for this reason, only one strain
was used for the following experiments
Table 3 Growth analysis of fungal strains in cross-streaking experiments carried out using Petri dishes
Target strains Fungal strains
Culture collection codes MUT
3588 3589 3596 3597 3610 3612 3613 3614 3615 3616 3617 3618 3632 3638
Staphylococcus aureus 6538P ± + + ± + + + ± ± + ± + + −
Pseudomonas aeruginosa PA01 + + ± ± + ± + + + ± + + ± +
Klebsiella pneumoniae DF12SA + + ± + ± + ± + ± ± ± ± ± −
Acinetobacter baumannii Ab13 ± ± + + + ± + + + + + + ± −
Burkholderia metallica LMG 24068 ± + + + ± + + ± ± ± + ± + −
Symbols: +, non-inhibition, ±, partial inhibition, −, full inhibition
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secondary metabolite production, a series of parameters was
changed.
The growth medium used for the first isolation (CYC) was
replaced with one richer medium (TYS) maintaining the same
concentration of salt (15%), in static conditions. In order to
evaluate the antimicrobial activity of crude extracts, liquid
inhibition assays were carried out against selected pathogenic
bacteria. Despite that MUT 3638 was able to inhibit the vast
major of pathogens (except P. aeruginosa) tested in the initial
screening, after the liquid screening of crude extracts, the
highest antimicrobial effect was detected towards
Staphylococcus aureus 6538P with a minimal inhibitory con-
centration (MIC) of 0.06 mg/mL.
MUT 3638 extract showed antimicrobial activity towards
all the tested strains with the exception of P. aeruginosa PA01.
MIC values were 0.12 mg/mL against both B. cenocepacia
strains and 0.5 mg/mL against K. pneumoniae and A.
baumannii Ab13.
The impact of NaCl concentration on the growth and anti-
microbial activity was then evaluated. The strain MUT 3638
was inoculated in TYSmediumwith varying NaCl concentra-
tions from 3 to 25% (w/v), and the inoculum was incubated in
the flask at 20 °C for 10 days. Interestingly, considering that
the sediments do not come from waters with high salinities,
MUT 3638 was able to grow from natural seawater (about 3%
of salinity) until 25% (w/v) of NaCl. Concerning the produc-
tion of metabolites, the best yield was obtained by adding
NaCl at a concentration of 10–15% (w/v). In fact, from
250 mL of culture yielded 17 mg of crude extracts in presence
of 10 and 15% of NaCl after 20 days of incubation. However,
the activity of extracts was identical for all conditions tested
(i.e. 60 μg/mL as per MIC results); therefore, the concentra-
tion of 10% NaCl was selected for growth optimisation.
The effects of incubation time, pH and temperature were
subsequently evaluated. To this aim, the fungus was inoculat-
ed in TYS medium with 10% (w/v) NaCl, varying pH (from
4.0 to 9.0) and temperature (10, 25 and 37 °C). The length of
incubation was 10 days and a second set for 25 days. After the
incubation, the antimicrobial activity was evaluated and re-
sults are summarised in Table 4.
Most fungi are mesophilic; however, few fungal species
can grow at low or high temperature (Deacon 2006). The A.
protuberus strain MUT 3638 has shown higher versatility,
with the ability to grow at low and high temperatures, and in
a wide range of salt concentrations and diverse pH range. This
particular behaviour makes this fungus a promising candidate
for biotechnological applications.
Extracts from growth at pH 4.0 and pH 9.0 displayed iden-
tical antimicrobial activities, while temperature proved to be a
key factor. The increase of temperature (25 and 37 °C) result-
ed in a higher yield and activity of the extract compared to the
one obtained from the growth at 10 °C. Moreover, prolonged
time of incubation also significantly affected the yield of the
extracts, but not an increase of its biomass. Extracts from
25 days of incubation weighed up to three times more than
their 10-day counterparts. This finding might suggest that the
production of the antimicrobial compounds is triggered by the
Table 4 Crude extract yield and
antimicrobial activity against S.
aureus of A. protuberus MUT
3638 species by optimising
growth conditions
Conditions tested Yield (mg) of crude
extract from 500 mL
exhausted broth
MIC (mg/mL)
against S. aureus
crude extractpH Incubation Time Temperature (°C)
pH 4.0 10 days 10 7 1
25 10 1
37 12 1
25 days 10 15 0.5
25 25 0.06
37 34 0.06
pH 9.0 10 days 10 7 1
25 9 1
37 12 1
25 days 10 14 0.25
25 30 0.06
37 38 0.06
Table 5 The inhibitory activity of fractions produced from the active
extract of A. protuberus MUT 3638 reported as percentage of inhibition
of target S. aureus 6538P
% Solvent Concentration [mg/mL]
1 0.5 0.25 0.12 0.06 0.03 0.015
25% MeOH 20 20 10 10 10 10 10
50% MeOH 30 30 20 20 20 10 10
100% MeOH 100 100 100 90 70 40 20
100% MetOH
+ 0.1% TFA
30 30 20 10 10 10 10
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activation of the organism’s secondary metabolism, in stressed
conditions, such as starvation.
Bioactivity-Guided Purification of Aspergillus
Bioactive Compounds
Once the best conditions for the production of antimicrobials
by A. protuberus MUT 3638 to counteract S. aureus 6538P
were established, an up-scaled fermentation was set up to
1.5 L. After 25 days of incubation, the exhausted broth was
extracted, yielding 250 mg of crude extract. The crude extract
was subsequently re-suspended in methanol and fractionated
using solid-phase extraction (SPE) C-18 column cartridge, by
using a water-methanol system as described in BMaterials and
Methods^ (BPurification of Active Compounds from the
Newly Isolated A. protuberusMUT 3638^).
Four fractions were collected, dried and used to perform
MIC assays against the pathogens. As reported in Table 5, the
fraction eluted with 100% MeOH displayed a strong antimi-
crobial activity, compared to the other samples with a MIC
between 0.25 and 0.112 mg/mL.
Subsequently, the 100% methanol fraction (88 mg) was
subjected to purification by reverse phase HPLC by using a
C-18 with an ACN/water linear gradient (as specified in
BMaterials and Methods,^ BPurification of Active
Compounds from the Newly Isolated A. protuberus MUT
3638^). The assay against S. aureus showed that the peak #
9 is responsible of the activity. The peak # 9 has a retention
time (RT) at minute = 26.534 and possesses a MIC of 30 μg/
mL and a yield of 3.6 mg.
Preliminary Metabolic Profiling by LC-HRMS Analysis
The metabolic profile of the crude 100%methanol fraction by
MUT 3638 strain was analysed by LC/HRMS analysis. The
molecular formulas were deduced by HRESI analysis, and the
corresponding structures were tentatively assigned by com-
parison with literature data (Harned and Volp 2011; Meng
et al. 2016). The results of this analysis were reported in
Table 6. The crude extract contained a complex mixture of
monomeric and dimeric members of sorbicillinoid family
This growing family of polyketide natural products is com-
prised of 90 members that have been mainly isolated from
fungi of terrestrial origin (Acremonium, Aspergillus,
Clonostachys, Emericella, Penicillium, Phaeoacremonium,
Scytalidium, Trichoderma and Verticillium genera) and in
few marine species (Paeci lomyces , Penici l l ium ,
Phialocephala, Trichoderma and Trichothecium genera).
Compound Identification
Bioassay-guided HPLC fractionation of the crude 100%
methanol extract revealed the antimicrobial activity exclusive-
ly associated to peak # 9. Combined HRESI MS, MSn and 1H
NMR analysis indicated that peak 9 is a pure compound. An
[M +H]+ quasi-molecular ion detected in the HRESIMS spec-
trum at m/z 513.2124 indicated the molecular formula
C28H32O9 (calculated for C28H33O9 513.2119) (see Fig. S3
supplemental material). The presence of a Na adducts at m/z
535.1939 was also observed.
The 1H NMR spectrum (see Fig. S4 supplemental material
and BMaterial and Methods^) of peak 9 showed signals super-
imposable to those reported for bisvertinolone (Trifonov et al.
1986). Indeed, the HRESI MS2 (see Fig. S5 supplemental
material) fragmentation pattern of peak 9 (precursor ion at
m/z 513.2) matched with the backbone of bisvertinolone and
furthermore was in good agreement with EIMS2 data—ac-
quired at unit resolution—reported by Trifonov et al. for
Table 6 Metabolite profiling for
sorbicillonoid components in the
culture broth of A. protuberus
MUT 3638 by LC-HRMS
analysis of its crude extract
Compound Formula [M+ H]+ (calculated) Retention time
(RT) (min)
Sorbicillin C14H16O3 233.1165 15.07
Sorbicillinol C14H16O4 249.1113 21.9
Dihydrosorbicillinol C14H18O4 251.1278 19.43
Oxosorbicillinol C14H16O5 265.1071 21.31
Sorbicillactone A C21H23 NO8 418.1502 10.60
Bisvertinol C28H34O8 499.2319 17.86
Bisvertinolone C28H32O9 513.2119 21.26
Dihydrobisvertinolone C28H34O9 515.2276 21.26
O
OH
O
O
H
OH
O
O
O
H
OH
Fig. 2 Structure of the bisvertinolone compound isolated from A.
protuberus MUT 3638
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bisvertinolone. These data led to confirm the identity of peak 9
as bivertinolone.
Bisvertinolone was obtained as a light yellow amorphous
powder. An [M + H]+ HRESI MS quasi-molecular ion detect-
ed at m/z 513.2124 suggested the molecular C28H32O9 (cal-
culated for C28H33O9 513.2119) (see Fig. S3 supplemental
material).
The compound was identified as bisvertinolone (Fig. 2) by
comparison of its optical and NMR data.
Bisvertinolone was firstly detected from the culture medi-
um of Verticillium intertextum (Trifonov et al. 1986) and later
described as the first β-1,6-glucan biosynthesis inhibitor from
the fungus Acremonium strictum (Kontani et al. 1994).
Several biological activities have been ascribed to members
of this family, including radical scavenger activity and anti-
proliferative activity. Although the data relative to the antipro-
liferative activity of the sorbicillinoids are fragmentary (Liu
et al. 2005), bisvertinolone represents one of the most active
compounds. Preliminary results seem to suggest the impor-
tance of two unsaturated sorbyl side chain in a correct relative
orientation for the observed cytostatic activity. As concerning
the antimicrobial activity, there are very few reports in the
literature dealing with the investigation of the antibacterial
activity of members of sorbicillinoid family. Somemonomeric
or dimeric sorbicillinoids demonstrated to possess weak activ-
ity against Staphylococcus aureus and Bacillus subtilis
(Maskey et al. 2005). Recently, two dimeric sorbicillinoids,
dihydrotrichodimerol and tetrahydrotrichodimerol, were re-
ported as potent antibacterial agents against Bacillus
megaterium with MIC values of 25 μg and 12.5 μg/mL, re-
spectively (Zhai et al. 2016).
Conclusions
By exploiting a bioassay-driven purification approach, the
bioactive compound bisvertinolone with antimicrobial activi-
ty against Staphyloccoccus aureus 6538P was isolated from a
new polyextremophilic fungus Aspergillus protuberus MUT
3638.
To the best of our knowledge, the antibacterial activity of
the bisvertinolone was demonstrated for the first time. Future
investigation will be focused on unveiling the mechanisms of
action and the scale-up production of the active compound.
Furthermore, this fungus was isolated from cold seawater,
but showed a great versatility to different environmental con-
ditions. In particular, it was able to grow in a wide salinity
range, as well as in varying ranges of pH and temperature.
This capability makes the new strain A. protuberus MUT
3638 an ideal candidate for biotechnological applications.
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